Globe Life Sciences

PHARMACEUTICALS

DIAGNOSTICS

PERSONALIZED MEDICINE

DEVICES

Pharmaceuticals

Encompasses prescription medicines across a range of modalities including small molecules, biologics (eg MAbs, RNAi), vaccines and stem cell therapies.

Diagnostics

Encompasses a range of In Vitro Diagnostics (IVD) sectors including blood glucose, haematology, immunoassays, microbiology and clinical chemistry.

Personalized Medicine

Encompasses developments also referred to as theranostics, molecular diagnostics, companion diagnostics and personalized healthcare initiatives.

Devices

Encompasses a range of sectors including cardiovascular devices (e.g. valves, stents), orthopaedic devices (e.g. knee implants), wound care management and minimally invasive surgery.

Europe and MENA

North America

Population: c. 343 million
GDP: c $16 trillion
Sources: US Census Bureau, Statistics Canada, IMF (US and Canada)

Europe & MENA

Population: c. 501 million
GDP: c. $16 trillion
Sources: Eurostat, IMF (EU only)

Japan

Population: c.127 million
GDP: c. $5 trillion
Sources: Japanese Statistics Bureau, IMF

Emerging Markets

Population: c. 2.8 billion
GDP: c. $11 trillion
Sources: CIA World Factbook, IMF (BRIC markets only)

Sectors

Recognising the range of interventions now possible via Life Sciences innovations, Globe works across a broad range of healthcare-related sectors.

Geography

Reflecting the evolution of healthcare provision around the world, Globe has expertise across a range of geographies.